Clinical Trial: Exploratory Clinical Study on Alzheimer's Disease Tau-Related Neurodegenerative Mechanisms Using XOR Inhibitor Combined with Nucleic Acid Metabolism Substrate Intervention (China)

China, Aug. 31 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Exploratory Clinical Study on Alzheimer's Disease Tau-Related Neurodegenerative Mechanisms Using XOR Inhibitor Combined with Nucleic Acid Metabolism Substrate Intervention'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131040

Registration Time: 2026/08/27

Type: Interventional study

Primary Sponsor: Guangdong Second Provincial General Hospital (Guangdong Provincial Emergency Hospital)

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338861

Published by HT Digital Content Services with permission from Health Daily Digest....